APA

Tung C., Chen J., Wu C., Peng Y., Chen W., Zheng H., Jian Y., Wei C., Cheng Y. & Lin Y. (20171003). Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. : Experimental cell research.

Chicago

Tung Chun-Liang, Chen Jyh-Cheng, Wu Chia-Hung, Peng Yi-Shuan, Chen Wen-Ching, Zheng Hao-Yu, Jian Yi-Jun, Wei Chia-Li, Cheng Ya-Ting and Lin Yun-Wei. 20171003. Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. : Experimental cell research.

Harvard

Tung C., Chen J., Wu C., Peng Y., Chen W., Zheng H., Jian Y., Wei C., Cheng Y. and Lin Y. (20171003). Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. : Experimental cell research.

MLA

Tung Chun-Liang, Chen Jyh-Cheng, Wu Chia-Hung, Peng Yi-Shuan, Chen Wen-Ching, Zheng Hao-Yu, Jian Yi-Jun, Wei Chia-Li, Cheng Ya-Ting and Lin Yun-Wei. Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. : Experimental cell research. 20171003.